Endogena Therapeutics Inc.

Endogena Therapeutics Inc.

Endogena Therapeutics is an early stage biotech company focusing on the discovery and development of first-in-class endogenous regenerative medicines. The novel drug discovery paradigm is based on the concept of selective regulation of endogenous progenitor cells for controlled tissue repair and regeneration. 

In Endogena's lead program, targeting retinal progenitor cells, they have established in-vitro proof-of-concept for retinal repair to restore vision, applicable for curative therapies in indications such as Retinitis Pigmentosa or dry AMD, both among the leading causes of blindness. Fast following programs have been initiated and focus on the expansion of this breakthrough concept in all three germ-layers and according developmental pathways.

Area of focus: 
Platform / research tool
Commencement date: 
09/15/2017

Share